Cite Filings / DXCM / 0001093557-21-000097
Feed Companies Filings Check
Sign in
PRE 14A

Proxy Statement (Preliminary)

DEXCOM INC · Filed 2021-03-26 · Acc 0001093557-21-000097

Documents 1

  • PRE 14A Proxy Statement (Preliminary) , dxcm-2021xpredef14aproxy_a.htm

Around this filing

  • 2022-03-25 PRE 14A Proxy Statement (Preliminary)
  • 2021-03-30 4 EVP, Chief Legal Officer sold 500 shares at $350.00 ($175,000)
  • 2021-03-26 PRE 14A Proxy Statement (Preliminary)
  • 2021-03-24 4 Managing Dir., Dexcom Ventures sold 1,079 shares at an average $360.49 ($388,967)
  • 2021-03-24 4 EVP Chief Commercial Officer sold 1,109 shares at an average $360.49 ($399,788)
  • 2021-03-23 8-K Executive or director change
  • 2017-03-22 PRE 14A Proxy Statement (Preliminary)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading dxcm-2021xpredef14aproxy_a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…